Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenues:        
Product revenues $ 1,580,826 $ 1,209,321 $ 4,013,531 $ 2,963,073
Other service revenues 35,507 33,709 100,818 93,663
Development services revenues 3,404 25,842
Total revenues 1,616,333 1,246,434 4,114,349 3,082,578
Cost of product revenues 748,305 560,394 1,965,839 1,340,824
Research and development costs 691,330 480,280 2,098,465 1,434,723
Selling, general, and administrative expenses 1,886,220 2,132,777 5,748,524 6,608,829
Restructuring charges     1,252,584
Operating loss (1,709,522) (1,927,017) (5,698,479) (7,554,382)
Other income (expense):        
Gain from change in fair value of derivative liabilities 324,035 1,950,329 748,080 981,222
Loss from debt restructuring (933,134) (811,909)
Other income (loss), net (4,877) 45,302 209,504 243,505
Interest income 1,317 2,692 7,775 14,887
Interest expense (241,050) (316,705) (843,983) (936,043)
Net loss $ (2,563,231) $ (245,399) $ (6,389,012) $ (7,250,811)
Net loss per share attributable to common stockholders:        
Basic and diluted (in dollars per share) $ (0.92) $ (0.13) $ (2.59) $ (3.87)
Weighted average shares outstanding:        
Basic and diluted (in shares) 2,779,803 1,872,823 2,467,437 1,871,974